New Hepatitis B Treatment Silences Virus in Early Trials
A breakthrough epigenetic therapy has successfully silenced the hepatitis B virus in human cells, mice, and monkeys without dangerous DNA cuts. The first human patient received the treatment in January, offering hope to 250 million people living with chronic hepatitis B worldwide.
